Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review

  • ID: 4395085
  • SWOT Analysis
  • 41 pages
  • GlobalData
  • Savara Pharmaceuticals
1 of 5

FEATURED COMPANIES

  • Adimab LLC
  • Apotex Inc
  • Gilead Sciences Inc
  • Novartis AG
  • Syntiron LLC
  • MORE
Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Savara Inc (Savara) formerly Mast Therapeutics Inc is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The company’s lead product candidates include Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of treatment of PAP; and AeroVanc, an inhaled formulation of vancomycin for the treatment of CF. Its development pipeline also includes Aironite, a sodium nitrite solution for intermittent inhalation for the treatment of heart failure. The company has subsidiaries in the US and Denmark. Savara is headquartered in Austin, Texas, the US.

Savara Inc Key Recent Developments

May 09, 2018: Savara Reports First Quarter 2018 Financial Results and Provides Business Update
Mar 14, 2018: Savara Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Jan 04, 2018: Savara Announces Appointment of Peter Ginsberg as Vice President of Business Development
Nov 08, 2017: Savara Reports Third Quarter 2017 Financial Results and Provides Business Update
Aug 09, 2017: Savara Reports Second Quarter 2017 Financial Results and Provides Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Adimab LLC
  • Apotex Inc
  • Gilead Sciences Inc
  • Novartis AG
  • Syntiron LLC
  • MORE
Section 1 - About the Company
  • Savara Inc - Key Facts
  • Savara Inc - Key Employees
  • Savara Inc - Key Employee Biographies
  • Savara Inc - Major Products and Services
  • Savara Inc - History
  • Savara Inc - Company Statement
  • Savara Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Savara Inc - Business Description
  • R&D Overview
  • Savara Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Savara Inc - Strengths
  • Savara Inc - Weaknesses
  • Savara Inc - Opportunities
  • Savara Inc - Threats
  • Savara Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Savara Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Savara Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Savara Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 09, 2018: Savara Reports First Quarter 2018 Financial Results and Provides Business Update
  • Mar 14, 2018: Savara Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
  • Jan 04, 2018: Savara Announces Appointment of Peter Ginsberg as Vice President of Business Development
  • Nov 08, 2017: Savara Reports Third Quarter 2017 Financial Results and Provides Business Update
  • Aug 09, 2017: Savara Reports Second Quarter 2017 Financial Results and Provides Business Update
  • May 01, 2017: Savara Secures $15 Million Loan And Security Agreement With Silicon Valley Bank
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Savara Inc, Key Facts
  • Savara Inc, Key Employees
  • Savara Inc, Key Employee Biographies
  • Savara Inc, Major Products and Services
  • Savara Inc, History
  • Savara Inc, Subsidiaries
  • Savara Inc, Key Competitors
  • Savara Inc, Ratios based on current share price
  • Savara Inc, Annual Ratios
  • Savara Inc, Annual Ratios (Cont...1)
  • Savara Inc, Interim Ratios
  • Savara Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Savara Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Savara Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Savara Inc, Performance Chart (2013 - 2017)
  • Savara Inc, Ratio Charts
  • Savara Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Savara Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Vertex Pharmaceuticals Inc
  • Syntiron LLC
  • Novartis AG
  • Integrated BioTherapeutics Inc
  • Gilead Sciences Inc
  • Apotex Inc
  • Adimab LLC
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll